logo
Share SHARE
FONT-SIZE Plus   Neg

Altisource Portfolio Q4 Profit Rises, Shares Up 10%

Mortgage investment company Altisource Portfolio Solutions S.A. (ASPS), Wednesday reported an increase in profit for the fourth quarter, reflecting strong growth at higher margin mortgage services segment. Following the announcement of results, Altisource shares are currently up ten percent on the Nasdaq.

Luxembourg-based Alticsource's fourth-quarter profit rose to $30.3 million or $1.20 per share from $25.73 million or $1.02 per share a year before.

Altisource said the bottom line growth was driven mainly by stronger service revenue growth in the higher margin mortgage services segment relative to the other segments.

Mortgage services segment rose to $92.0 million from $77.2 million last year, while financial services dropped to $14.9 million from $16.2 million last year. Technology services division advanced to $20.2 million from $15.0 million last year.

Altisource said total revenues grew to $141.1 million from $132.0 million last year.

Commenting on the results, Chief Executive William Shepro said, "2012 was a very strong year for Altisource. We focused on providing high quality services to our largest customer, Ocwen Financial Corporation, while intensifying our efforts on our strategic initiatives to diversify and expand our revenue base."

Altisource expects 2013 to be a strong year and 2014 to be even stronger, reflecting the growth recently experienced by Ocwen and its announced plans for future growth.

ASPS is currently trading at $91.44, up $7.58 or 9.04%.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT